To determine the outcome of DSM-III-R schizophreniform disorder with good prognostic features.
Method:
A 6-year follow-up of 20 cases was conducted with structured interviews (comprehensive assessment of symptoms and history) and assessments of functioning scales (global assessment of functioning, Strauss–Carpenter Scale).
Results:
Thirty-five percent of the cases had major affective disorders, 35% had schizophreniform episodes and major affective disorders, 5% had schizophreniform episodes only, 10% developed schizophrenia, and 15% had no disorders.
Conclusion:
The findings suggest an association between schizophreniform disorder with good prognostic features and affective illness.
BenazziFMazzoliMRossiE. A follow-up and family study of DSM-III-R schizophreniform disorder with good prognostic features. Eur Arch Psychiatry Clin Neurosci1992;242:119–21.
2.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Revised.Washington (DC): American Psychiatric Press; 1987.
3.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.Washington (DC): American Psychiatric Press; 1994.
4.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed.Washington (DC): American Psychiatric Press; 1980.
5.
CoryellWTsuangMT. Major depression with mood-congruent or mood-incongruent psychotic features: Outcome after 40 years. Am J Psychiatry1985;142:479–82.
6.
OpjordsmoenS. Paranoid (delusional) disorders in the light of a long-term follow-up study. Psychopathology1991;24:287–92.
7.
RetterstolN. Course and outcome in paranoid disorders. Psychopathology1991;24:277–86.
8.
GuldbergCADahlAABergemM. Predictive value of the four good prognostic features in DSM-III-R schizophreniform disorder. Acta Psychiatr Scand1990;82:23–5.
9.
MollerHJHohe-SchrammMCording-TommelCSchmid-BodeWWittchenHU, Zaudig M, and others. The classification of functional psychoses and its implication for prognosis. Br J Psychiatry1989;154:467–72.
10.
VitaAGiobbioGMGarbariniMMorgantiCDieciM. Prognostic value of ventricular enlargement in acute schizophreniform disorder [letter]. Lancet1994;338:1458.
11.
FogelsonDLCohenBMPopeHG. A study of DSM-III schizophreniform disorder. Am J Psychiatry1982;139:1281–5.
12.
OpjordsmoenS. Long-term follow-up of paranoid psychoses. Psychopathology1986;19:44–9.
13.
BeiserMFlemingJAIaconoWGLinT. Refining the diagnosis of schizophreniform disorder. Am J Psychiatry1988;145:695–700.
14.
OpjordsmoenS. Delusional disorders: Part I. Comparative long-term outcome. Acta Psychiatr Scand1989;80:603–12.
15.
CoryellWTsuangMT. DSM-III schizophreniform disorder. Comparison with schizophrenia and affective disorder. Arch Gen Psychiatry1982;39:66–9.
16.
CoryellWTsuangMT. Outcome after 40 years in DSM-III schizophreniform disorder. Arch Gen Psychiatry1986;43:324–8.
17.
TaylorMAAbramsR. Mania and DSM-III schizophreniform disorder. J Affect Disord1984;6:19–24.
18.
PulverAEBrownHWolyniecPSMcGrathJATarnD. Psychiatric morbidity in the relatives of patients with DSM-III schizophreniform disorder: Comparisons with the relatives of schizophrenic and bipolar patients. J Psychiatr Res1991;25:19–29.
19.
KendlerKSGruenbergAMTsuangMT. A DSM-III family study of nonschizcphrenic psychotic disorders. Am J Psychiatry1986;143:1098–1105.
20.
TargumSD. Neuroendocrine dysfunction in schizophreniform disorder: Correlation with six-month clinical outcome. Am J Psychiatry1983;140:309–13.
21.
KatsanisJIaconoWGBeiserM. Relationship of lateral ventricular size to psychophysiological measures and short-term outcome. Psychiatry Res1991;37:115–29.
22.
BudaMTsuangMTFlemingJA. Causes of death in DSM-III schizophrenics and other psychotics (atypical group). A comparison with the general population. Arch Gen Psychiatry1988;45:283–5.
23.
KendlerKSWalshD. Schizophreniform disorder, delusional disorder and psychotic disorder not otherwise specified: Clinical features, outcome and familial psychopathology. Acta Psychiatr Scand1995;91:370–8.
24.
KendlerKSMcGuireMGruenbergAMO'HareASpellmanMWalshD. The Roscommon family study: Part I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry1993;50:527–40.
25.
DelisiLEStritzkePRiordanHHolanVBoecioA, Kushner M, and others. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biol Psychiatry1992;31:241–54.
26.
McDermottBESautterFJGarverDL. Heterogeneity of schizophrenia: Relationship to latency of neuroleptic response. Psychiatry Res1991;37:97–103.
27.
HoffALRiordanHO'DonnelDWMorrisLDelisiLE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry1992;149:898–903.
28.
DelisiLEHoffALKushnerMCalevAStritzkeP. Left ventricular enlargement associated with diagnostic outcome of schizophreniform disorder. Biol Psychiatry1992;32:199–201.
29.
StrakowskiSM. Diagnostic validity of schizophreniform disorder. Am J Psychiatry1994;151:815–24.
30.
AndreasenNCFlaumMArndtS. The comprehensive assessment of symptoms and history (CASH). Arch Gen Psychiatry1992;49:615–623.
31.
StraussSJCarpenterWT. The prediction of outcome in schizophrenia: Part I. Characteristics of outcome. Arch Gen Psychiatry1972;27:739–46.
32.
GrossmanLHarrowMGoldbergJFFichtnerCG. Outcome of schizoaffective disorder at two long-term follow-ups: Comparisons with outcome of schizophrenia and affective disorders. Am J Psychiatry1991;148:1359–65.
33.
KendlerKS. Mood-congruent psychotic affective illness. Arch Gen Psychiatry1991;48:362–9.
